UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024884
Receipt number R000028635
Scientific Title Efficacy of tobacco cessation for improving oral diseases - multicentre trial
Date of disclosure of the study information 2016/11/18
Last modified on 2016/11/17 19:57:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of tobacco cessation for improving oral diseases - multicentre trial

Acronym

Multicentre trial for tobacco cessation of oral diseases

Scientific Title

Efficacy of tobacco cessation for improving oral diseases - multicentre trial

Scientific Title:Acronym

Multicentre trial for tobacco cessation of oral diseases

Region

Japan


Condition

Condition

Oral Diseases;
Periodontitis
Patients for implant treatment
Oral mucosal diseases (nicotine stomatitis, oral leukoplakia, erythloplakia and oral lichen planus)

Classification by specialty

Oral surgery Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the efficacy of tobacco cessation intervention for oral diseases

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical improvement of each disease (12 months after the treatment)
Periodontitis- Probing pocket depth and clinical attachment level of two sites with the deepest periodontal pocket (6 mm or more)

Implant- one-year implant survival and per-implant marginal bone loss the day after implant placement and after 1 year measured by a standardized X-ray photo

Oral mucosal diseases-size reduction (major x minor axis /mm) at a predominant site for non-surgical group and recurrence rate for surgical group

Key secondary outcomes

Tobacco abstinence rate at each observation period at 3, 6, 12, 24 months for each disease group


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Behavior,custom

Interventions/Control_1

Cessation intervention with or without NRT(nicitine replace therapy using nicitine patch or nicotine gum) for 12 weeks for those who intention to abstinence from smoking and having 3 points or more in FTND (Fagerstrom Test for Nicotine Dependence) test

Interventions/Control_2

Non tobacco cessation intervention for those who do not intention to abstinence from smoking strongly and having less than 3 points in FTND (Fagerstrom Test for Nicotine Dependence) test

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Periodontitis patients who have
30% or more of the sites with 4 mm or more probing pocket depth and 3 sites
or more with 6 mm or more probing depth

Patients for implant treatment; about to implant placement for their tooth loss

Oral mucosal diseases; having a pathological diagnosis and clinically diagnosed for nicotine stomatitis, oral leukoplakia, erythloplakia and oral lichen planus

Key exclusion criteria

Less than 20 years old
Already having any cessation intervention
Having had periodontal treatment within 6 months
Periodontitis patients who have anti-inflammatory drug or steroid use
Patients for implant treatment; N/A
Oral mucosal diseases; have had surgical resections before or other interventional treatments

In case of use of nicotine replacement therapy (NRT);already have a prescription of NRTs or medicines, pregnant and breastfeeding women, has unstable angina pectoris, in the immediate (within 3 months) past myocardial infarction period, have serious arrhythmias, post-percutaneous coronary intervention (PCI), post-coronary artery bypass graft (CABG), early period of recovery from cerebrovascular disease

Target sample size

812


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinsaku Arai

Organization

Kyushu University Hospital

Division name

Department of Oral and Maxillofacial Surgery

Zip code


Address

3-1-1, Maidaishi, Higashi-ku, Fukuoka, 812-8582, Japan

TEL

092-642-6447

Email

aratube@dent.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hitoshi Nagasu

Organization

Japanese Academy of Maxillofacial Implant

Division name

Secretariat

Zip code


Address

5-29-22-805,Shiba, Minato-ku, Tokyo,108-0014, Japan

TEL

03-3451-6916

Homepage URL

http://www.jamfi.net/tisod///index.html

Email

jamioffice@gmail.com


Sponsor or person

Institute

Tobacco Cessation Intervention Study Team for Oral Diseases (TISOD)

Institute

Department

Personal name



Funding Source

Organization

Japanese Academy of Maxillofacial Implant

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Japanese Association for Dental Science

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT02737176

Org. issuing International ID_1

ClinicalTrials. Gov

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2016 Year 02 Month 24 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 18 Day

Last follow-up date

2018 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 11 Month 17 Day

Last modified on

2016 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028635


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name